prazosin has been researched along with pyrazines in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MC; Cragoe, EJ; Daniel, EE; Gaspar, V; Kwan, CY; Ohta, A; Shi, AG; Wang, ZL | 1 |
| Cresson, EL; Hartman, RD; Huff, JR; Lumma, WC; Lyon, TF; Randall, WC | 1 |
| Berg, T | 1 |
| Chen, L; Huang, F; Li, W; Li, X; Liu, Z; Luo, Z; Wu, H; Xu, Y; Young, C; Zhou, S | 1 |
4 other study(ies) available for prazosin and pyrazines
| Article | Year |
|---|---|
Vascular effects of tetramethylpyrazine: direct interaction with smooth muscle alpha-adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amiloride; Animals; Azepines; Binding, Competitive; Dogs; In Vitro Techniques; Microsomes; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Prazosin; Pyrazines; Radioligand Assay; Receptors, Adrenergic, alpha; Vasodilator Agents | 1991 |
Piperazinylimidazo[1,2-a]pyrazines with selective affinity for in vitro alpha-adrenergic receptor subtypes.
Topics: Animals; Binding, Competitive; Cattle; Cerebral Cortex; Clonidine; Magnetic Resonance Spectroscopy; Prazosin; Pyrazines; Receptors, Adrenergic; Receptors, Adrenergic, alpha | 1983 |
The vascular response to the K+ channel inhibitor 4-aminopyridine in hypertensive rats.
Topics: 4-Aminopyridine; Adrenalectomy; Adrenergic Antagonists; Amifampridine; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Indomethacin; Losartan; Male; Muscarinic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phentolamine; Potassium Channel Blockers; Prazosin; Protein Kinase C; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Staurosporine; Sulfonamides; Vascular Resistance; Vasoconstriction | 2003 |
The novel compound liguzinediol exerts positive inotropic effects in isolated rat heart via sarcoplasmic reticulum Ca2+ ATPase-dependent mechanism.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Caffeine; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart; Male; Myocardial Contraction; Myocytes, Cardiac; Nimodipine; Ouabain; Prazosin; Propranolol; Pyrazines; Rats; Rats, Sprague-Dawley; Ruthenium Red; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thapsigargin | 2012 |